Acceleron Pharma, Inc.: Series D $30.4M

Posted in I - Series D, Q - 4Q11, R - NORTH EAST, X - Anemia, X - Muscular Dystrophy, X - Oncology, X - Osteoporosis, XX - MA

Acceleron Pharma (Cambridge, MA) is a clinical-stage biopharmaceutical company focused on protein therapeutics for anemia, cancer, Duchenne Muscular Dystrophy and bone loss diseases, closed a $30.4M Series D financing. Participants have included Advanced Technology Ventures, Avalon Ventures, Bessemer Venture Partners, Celgene, Flagship Ventures, MPM Capital, Orbimed, Polaris Ventures, QVT Financial, Sutter Hill Ventures and Venrock.

Jul

2011

Akebia Therapeutics, Inc.: Series B $22M

Posted in I - Series B, Q - 2Q11, R - MID WEST, X - Anemia, X - Vascular, XX - OH

Akebia Therapeutics (Cincinnati, OH) a clinical-stage pharmaceutical focused on anemia and vascular disorders, closed a $22M Series B financing. Participants include Novartis Venture Fund, Venture Investors, Triathlon Medical Ventures, Kearny Venture Partners, Athenian Venture Partners, Sigvion Capital and AgeChem.

Jul

2010

FerroKin Biosciences, Inc.: Series B $12M

Posted in I - Series B, Q - 2Q10, R - WEST, X - Anemia, XX - CA

FerroKin Biosciences (San Carlos, CA) a preclinical-stage biopharmaceutical company focused on iron chelator for treatment of anemia, closed a $12M Series B financing. Participants include Clarus Ventures, Burrill & Co., Celegene, MP Healthcare Venture Management and Healthcap Ventures.

Sep

2009

Akebia Therapeutics, Inc.: Series A $16M

Posted in I - Series A, Q - 3Q09, R - MID WEST, X - Anemia, X - Vascular, XX - OH

Akebia Therapeutics (Cincinnati, OH) a clinical-stage biopharmaceutical company focused on the development of small-molecules for anemia and vascular disease, closed a $16M Series A bringing the total financing to $25M. Participants include Novartis Venture Fund, Venture Investors, Triathlon Medical Ventures, Kearny Venture Partners, Athenian Venture Partners and Sigvion Capital.

Dec

2008

FerroKin Biosciences, Inc.: Series A $15

Posted in I - Series A, Q - 4Q08, R - WEST, X - Anemia

FerroKin Biosciences (San Carlos, CA) early-stage developer of iron chelator for treatment of anemias, closed a $15M Series A financing. Participants include Clarus Ventures, Burrill & Co. and Celegene Inc.

to top of page...